In last trading session, Mira Pharmaceuticals Inc (NASDAQ:MIRA) saw 2.47 million shares changing hands with its beta currently measuring 2.01. Company’s recent per share price level of $1.25 trading at $0.25 or 25.00% at ring of the bell on the day assigns it a market valuation of $20.70M. That closing price of MIRA’s stock is at a discount of -300.8% from its 52-week high price of $5.01 and is indicating a premium of 59.2% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.42 million shares which gives us an average trading volume of 305.82K if we extend that period to 3-months.
Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information
Upright in the green during last session for gaining 25.00%, in the last five days MIRA remained trading in the green while hitting it’s week-highest on Thursday, 03/13/25 when the stock touched $1.25 price level, adding 5.87% to its value on the day. Mira Pharmaceuticals Inc’s shares saw a change of 9.65% in year-to-date performance and have moved 23.76% in past 5-day. Mira Pharmaceuticals Inc (NASDAQ:MIRA) showed a performance of 9.65% in past 30-days. Number of shares sold short was 0.71 million shares which calculate 3.09 days to cover the short interests.
Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders
Insiders are in possession of 23.68% of company’s total shares while institution are holding 6.76 percent of that, with stock having share float percentage of 8.86%. Investors also watch the number of corporate investors in a company very closely, which is 6.76% institutions for Mira Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 117.82 shares of worth $0.15 million or 0.71% of the total outstanding shares. The later fund manager was in possession of 59.5 shares on Dec 31, 2024 , making its stake of worth around $74375.0 in the company or a holder of 0.36% of company’s stock.
